跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dipentum 250mg Capsules - TGA Drug Approval Details
Approvals
/
TGA
/
Dipentum 250mg Capsules
Approved
STANDARD
Dipentum 250mg Capsules
Atnahs Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
171ff2d703833033
Company
Atnahs Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
171ff2d703833033
Product Name
Dipentum 250mg Capsules
Artg Id
14466
Artg Name
DIPENTUM olsalazine sodium 250mg capsule bottle
Sponsor
Atnahs Pharma Australia Pty Ltd
Company Detail Path
/organization/atnahs-pharma-australia-pty-ltd
Artg Date
1991-09-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/94ec2239178e9990730960ceed5863ca.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/39b36c17054e16d69cb31e9a2a6ac753.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
171ff2d703833033
Type
Standard
Back to TGA Approvals